Medexus Pharmaceuticals Inc
TSX:MDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Greenlane Renewables Inc
TSX:GRN
|
CA |
|
Avacta Group PLC
LSE:AVCT
|
UK |
|
A
|
Ashtead Group PLC
OTC:ASHTF
|
UK |
|
Taboola.com Ltd
F:1FY
|
US |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
Hofseth Biocare ASA
OSE:HBC
|
NO |
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
A
|
Atlassian Corp
SWB:48D
|
US |
|
Shimano Inc
F:SHM1
|
JP |
|
Henkel AG & Co KGaA
OTC:HENOF
|
DE |
|
China Life Insurance Co Ltd
SSE:601628
|
CN |
|
Banco Santander SA
MAD:SAN
|
ES |
|
Singapore Technologies Engineering Ltd
SGX:S63
|
SG |
|
Kingfa Science and Technology (India) Ltd
NSE:KINGFA
|
IN |
|
National Fertilizers Ltd
NSE:NFL
|
IN |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
F
|
Fabasoft AG
XBER:FAA
|
AT |
|
Gecina SA
PAR:GFC
|
FR |
|
F
|
FirstService Corp
NASDAQ:FSV
|
CA |
|
Indigo Books and Music Inc
F:5DA
|
CA |
|
A
|
Alphabet Inc
SGO:GOOGL
|
US |
|
N
|
NetClass Technology Inc
NASDAQ:NTCL
|
CN |
Wall St Price Targets
MDP Price Targets Summary
Medexus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for MDP is 7.48 CAD with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDP's stock price target?
Price Target
7.48
CAD
According to Wall Street analysts, the average 1-year price target for MDP is 7.48 CAD with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
What is the Revenue forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 12 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 5 years is 33%.
What is the Net Income forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
119%
The compound annual growth rate for Net Income over the next 3 years is 119%.
